Image 1_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.tif by Xinyi Lyu (14756739)

“…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”

Table 1_The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and pulmonary function: evidence from NHANES 2007–2012.docx by Miaoyan Liu (11943570)

“…</p>Results<p>The results manifested a significant correlation between decreased FEV1 and FVC values and elevated NHHR, most notably within the highest quartile of NHHR (Q4), where the association was most pronounced. …”

Image 2_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.tif by Xinyi Lyu (14756739)

“…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”

Table 1_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

“…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”

Data Sheet 1_Factors influencing the length of hospital stay of people experiencing homelessness.docx by Renate Karpenko (20858510)

“…</p>Conclusion<p>Gender had no significant effect on the LOS. The significant demographic factor was the duration of homelessness, indicating that the health status of PEH deteriorates and access to healthcare decreases over time. …”

Table 3_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

“…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”

<b>Metabolic flux analysis revealed </b><b>key roles of </b><b>ArcB</b><b> in ADI pathway and IlvC in BCAA </b><b>biosynthesis </b><b>during </b><b><i>Streptococcus suis</i></b><b>... by Hao Tang (21218903)

“…Transcriptome analysis found a significant suppression of many central metabolic genes during anaerobic growth of <i>S. suis</i>. …”

Supplementary file 1_Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis.docx by Ping Qi (772738)

“…</p>Results<p>(1) Gut microbiota showed no α-diversity difference between groups, but β-diversity differed significantly. PVT patients had increased Gram-negative bacteria (such as Escherichia-Shigella) and decreased SCFA-producing taxa. (2) Compared with peripheral vein microbiota, portal vein microbiota showed significant difference in α diversity and β diversity in cirrhotic patients with PVT, with Massilia enriched. (3) Portal microbiota had the highest diagnostic value for PVT (AUC = 0.95). (4) The tPVT group had more portal-feces shared genera than the tNPVT group (49 vs. 29). …”

Table 5_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

“…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”

<i>Lefty1</i> and <i>Lefty2</i> are regulated by separate proximal enhancer regions in mouse embryonic stem cells. by Tiegh Taylor (5791382)

“…Deletion of the <i>Lefty2</i> enhancer abolishes <i>Lefty2</i> expression while significantly decreasing both <i>Lefty1</i> and <i>Pycr2</i> transcripts. …”

DataSheet1_Efficacy of combination therapy of vitamin D and bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis.zip by Yuangui Yang (6746633)

“…However, the combination of VitD and bisphosphonates did not show a significant advantage over monotherapy in terms of improving osteocalcin levels. …”

Pioneering study - Impact of positive thinking on patients with chronic pain by Dr. Ivan Edwards (19855689)

“…</p><p dir="ltr">Conversely, the intervention group showed significant positive outcomes. Of the 113 patients, 105 reported a decreased perception of pain, suggesting a substantial impact of the positive thinking exercises. …”

Table 4_Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis.xlsx by Xinyi Lyu (14756739)

“…IHF and FCM validated that, at the cellular level, T, B, M1 cells were significantly reduced, and M2 cells were significantly decreased after EPO treatment. …”

Table 1_Inflammatory parameters mediates the relationship between dietary index for gut microbiota and frailty in middle-aged and older adults in the United States: findings from a... by Qijiang Yang (21096683)

“…RCS showed that the risk of frailty decreased linearly with increasing DI-GM levels. Mediation analysis indicated significant effects for leukocyte count, neutrophil count, NLR, and SIRI, with mediation proportions of 5.7, 7.9, 4.4, and 5.5%, respectively (all p < 0.001).…”

Multivariate statistical analysis diagram. by Ying Zhang (40767)

“…The separation pattern was satisfactory, with significant differences in principal components among the groups, indicating that the metabolic profiles underwent significant alterations between different groups. …”

Effects of contralateral noise on CAEP (Lee et al., 2025) by Donguk Lee (21628297)

“…The presentation of contralateral noise had a significant effect on P1 and N1 latencies, both of which decreased. …”

Image 3_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”

Table 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.docx by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”

Image 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”

Table 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.doc by Qianyi Zhou (6196383)

“…</p>Results<p>Of these, 17 patients received tocilizumab, resulting in a significant reduction in the duration of grade 3 CRS compared to those who did not receive the drug. …”